TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15521 · Feb 25

#rust#ai_gateway#ai_gateway_support#envoy#envoyproxy#gateway#generative_ai#llm_gateway#llm_inference#llm_proxy#llm_routing#llmops#llms#openai#prompt#proxy#proxy_server#routing Plano is an AI-native proxy server that handles key tasks for agentic apps like routing between agents, smart LLM model selection, safety guardrails, and automatic traces for observability. Define agents in simple YAML, write basic HTTP code in any language, and start Plano to run multi-agent systems without custom plumbing or framework lock-in. You benefit by building and shipping reliable agents to production much faster, focusing on core logic while gaining safety, low latency, and easy scaling. https://github.com/katanemo/plano

Results

3 similar posts found

Search: #clinicalstage

当前筛选 #clinicalstage清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3534 · 12/20/2024, 09:31 AM

$2.16M Fundraising by Umecrine Umecrine Cognition, a Swedish clinical-stage pharmaceutical firm, has raised $2.16 million to advance its innovative drug development targeting neurological disorders. The funding round took place on December 19, 2024. #UmecrineCognition#Pharmaceuticals#NeurologicalDisorders#Funding#Healthcare#ClinicalStage#Sweden

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 12/18/2024, 12:11 PM

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform